We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

150 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $15.5M

55% more capital invested

Capital invested by funds: $1.85B → $2.87B (+$1.02B)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

6% more funds holding

Funds holding: 141 → 150 (+9)

0.39% more ownership

Funds ownership: 16.7% → 17.09% (+0.39%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
150
Holders Change
+9
Holders Change %
+6.38%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
32
Increased
50
Reduced
50
Closed
22
Calls
$47.7M
Puts
$15.5M
Net Calls
+$32.2M
Net Calls Change
+$25.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$179M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M
4
ITP
Iron Triangle Partners
Connecticut
+$20.9M
5
SC
Samlyn Capital
New York
+$19.2M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$106M
2
BBA
Baker Bros. Advisors
New York
-$48.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$25.9M
4
PA
Perceptive Advisors
New York
-$22.4M
5
CII
Capital International Inc
California
-$22.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
151
Wells Fargo
California
$1K – – –
PA
152
Perceptive Advisors
New York
– -$22.4M -616,141 Closed
Two Sigma Investments
153
Two Sigma Investments
New York
– -$6.68M -183,862 Closed
Renaissance Technologies
154
Renaissance Technologies
New York
– -$6.58M -181,100 Closed
Marshall Wace
155
Marshall Wace
United Kingdom
– -$4.66M -128,290 Closed
OWP
156
Old Well Partners
North Carolina
– -$2.9M -79,700 Closed
Arrowstreet Capital
157
Arrowstreet Capital
Massachusetts
– -$1.76M -48,365 Closed
Two Sigma Advisers
158
Two Sigma Advisers
New York
– -$1.29M -35,600 Closed
JF
159
Jump Financial
Illinois
– -$1.27M -34,893 Closed
Qube Research & Technologies (QRT)
160
Qube Research & Technologies (QRT)
United Kingdom
– -$1.09M -30,032 Closed
Vontobel Holding
161
Vontobel Holding
Switzerland
– -$1.01M -27,258 Closed
Susquehanna International Group
162
Susquehanna International Group
Pennsylvania
– -$1.09M -25,930 Closed
KWMG
163
King Wealth Management Group
Florida
– -$436K -12,000 Closed
AIMCA
164
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$406K -11,183 Closed
QT
165
Quantbot Technologies
New York
– -$396K -10,900 Closed
Victory Capital Management
166
Victory Capital Management
Texas
– -$340K -8,464 Closed
TI
167
Trexquant Investment
Connecticut
– -$304K -8,366 Closed
N
168
Natixis
France
– -$290K -7,974 Closed
FC
169
FORA Capital
Florida
– -$269K -7,284 Closed
PM
170
Parametrica Management
Hong Kong
– -$220K -6,064 Closed
Simplex Trading
171
Simplex Trading
Illinois
– -$71K -1,681 Closed
CG
172
Cutler Group
California
– -$33.8K -800 Closed
3 4 5 6
7

LEGN Hedge Fund Activity: Q2 2022 in Review

150 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2022, worth a combined $2.87B — up 55% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LEGN positions and 22 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was HHLR Advisors, cutting an estimated $106M.

  • 150 institutional investors held Legend Biotech (LEGN) as of Q2 2022, up from 141 in Q1 2022.
  • Funds reported $2.87B of Legend Biotech stock for Q2 2022, up 55% quarter-over-quarter.
  • 32 funds opened new Legend Biotech positions in Q2 2022 and 22 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q2 2022 was Fidelity Investments, an estimated $179M added.
  • The largest Legend Biotech seller in Q2 2022 was HHLR Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2022.